These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 38268231)
1. Cost-of-illness and Economic Evaluation of Interventions in Children and Adolescents With Chronic Pain: A Systematic Review. Kitschen A; Wahidie D; Meyer D; Rau LM; Ruhe AK; Wager J; Zernikow B; Sauerland D Clin J Pain; 2024 May; 40(5):306-319. PubMed ID: 38268231 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of surgical treatment compared to medical treatment in patients with drug-refractory epilepsy: A systematic review. Kitschen A; Aleknonytė-Resch M; Sakalytė G; Diederich F Eur J Neurol; 2023 Mar; 30(3):749-761. PubMed ID: 36371643 [TBL] [Abstract][Full Text] [Related]
3. The humanistic and economic burden of systemic lupus erythematosus : a systematic review. Meacock R; Dale N; Harrison MJ Pharmacoeconomics; 2013 Jan; 31(1):49-61. PubMed ID: 23329592 [TBL] [Abstract][Full Text] [Related]
4. Economic evaluations of non-pharmacological interventions and cost-of-illness studies in bipolar disorder: A systematic review. Kraiss JT; Wijnen B; Kupka RW; Bohlmeijer ET; Lokkerbol J J Affect Disord; 2020 Nov; 276():388-401. PubMed ID: 32871669 [TBL] [Abstract][Full Text] [Related]
5. The economic burden of Chagas disease: A systematic review. Andrade MV; Noronha KVMS; de Souza A; Motta-Santos AS; Braga PEF; Bracarense H; de Miranda MCC; Nascimento BR; Molina I; Martins-Melo FR; Perel P; Geissbühler Y; Quijano M; Machado IE; Ribeiro ALP PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011757. PubMed ID: 37992061 [TBL] [Abstract][Full Text] [Related]
6. The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review. Mac S; da Silva SR; Sander B PLoS One; 2019; 14(1):e0210280. PubMed ID: 30608986 [TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review. von der Warth R; Dams J; Grochtdreis T; König HH Eur J Psychotraumatol; 2020 May; 11(1):1753940. PubMed ID: 33488993 [TBL] [Abstract][Full Text] [Related]
9. Influencing Factors of Transportation Costs Regarding Healthcare Service Utilization in Korea. Jang SY; Seon JY; Oh IH J Korean Med Sci; 2020 Sep; 35(35):e290. PubMed ID: 32893520 [TBL] [Abstract][Full Text] [Related]
10. Cost of illness for bipolar disorder: a systematic review of the economic burden. Kleine-Budde K; Touil E; Moock J; Bramesfeld A; Kawohl W; Rössler W Bipolar Disord; 2014 Jun; 16(4):337-53. PubMed ID: 24372893 [TBL] [Abstract][Full Text] [Related]
11. Overview of the economic burden of musculoskeletal pain in children and adolescents: a systematic review with meta-analysis. Espirito Santo CM; Santos VS; Kamper SJ; Williams CM; Miyamoto GC; Yamato TP Pain; 2024 Feb; 165(2):296-323. PubMed ID: 37755391 [TBL] [Abstract][Full Text] [Related]
12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [TBL] [Abstract][Full Text] [Related]
13. Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review. Zemedikun DT; Kigozi J; Wynne-Jones G; Guariglia A; Roberts T PLoS One; 2021; 16(5):e0251406. PubMed ID: 33974661 [TBL] [Abstract][Full Text] [Related]
14. How much is the cost of multiple sclerosis--systematic literature review. Kolasa K Przegl Epidemiol; 2013; 67(1):75-9, 157-60. PubMed ID: 23745380 [TBL] [Abstract][Full Text] [Related]
15. The economic costs of chronic pain among a cohort of treatment-seeking adolescents in the United States. Groenewald CB; Essner BS; Wright D; Fesinmeyer MD; Palermo TM J Pain; 2014 Sep; 15(9):925-33. PubMed ID: 24953887 [TBL] [Abstract][Full Text] [Related]
16. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review. Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330 [TBL] [Abstract][Full Text] [Related]
17. Cost of adult chronic rhinosinusitis: A systematic review. Smith KA; Orlandi RR; Rudmik L Laryngoscope; 2015 Jul; 125(7):1547-56. PubMed ID: 25640115 [TBL] [Abstract][Full Text] [Related]
18. Costs of informal nursing care for patients with neurologic disorders: A systematic review. Diederich F; König HH; Mietzner C; Brettschneider C Neurology; 2018 Jan; 90(1):28-34. PubMed ID: 29196573 [TBL] [Abstract][Full Text] [Related]
19. Economic burden of urgency urinary incontinence in the United States: a systematic review. Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314 [TBL] [Abstract][Full Text] [Related]
20. [Chronic pain in children and adolescents: an economic perspective]. Ruhe AK; Wager J; Linder R; Meusch A; Pfenning I; Zernikow B Schmerz; 2020 Apr; 34(2):133-139. PubMed ID: 32020302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]